Silver Book Fact

Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified as potential targets for future therapies.

Apkarian V. The Brain in Chronic Pain: Clinical implications. Pain Manag. 2011; 1(6): 577-86. http://www.futuremedicine.com/doi/abs/10.2217/pmt.11.53

Reference

Title
The Brain in Chronic Pain: Clinical implications
Publication
Pain Manag
Publication Date
2011
Authors
Apkarian V
Volume & Issue
Volume 1, Issue 6
Pages
577-86
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord…  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.  
  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.